-
Bayer AG arm Vividion Therapeutics doses first patient in Phase I study of Inhibitor for advanced solid tumors treatment
04 Apr 2025 15:11 GMT
… and independently operated subsidiary of Bayer AG, utilizing innovative discovery technologies to …
-
Europe’s Hormone Replacement Therapy Boom: What’s Driving the Market in 2024?
06 Apr 2025 07:06 GMT
… players such as Pfizer Inc., Bayer AG, Novo Nordisk A/S …
-
Trump Urges Americans to ‘Hang Tough’ as Tariffs Trigger Concerns and Market Freefall
05 Apr 2025 18:02 GMT
… cancer-related claims remain pending. Bayer AG is turning to the U …
-
Bayer asks high court to take $1.25 million Roundup appeal
05 Apr 2025 12:45 GMT
Bayer AG said it’s seeking a …
-
Vividion Therapeutics doses first patient in phase I study of RAS-PI3Ka inhibitor to treat advanced solid tumours
04 Apr 2025 10:43 GMT
… and independently operated subsidiary of Bayer AG, utilizing innovative discovery technologies to … and independently operated subsidiary of Bayer AG, is a clinical stage biopharmaceutical …
-
Bayer to launch groundbreaking products with blockbuster potential in 2025
04 Apr 2025 09:58 GMT
… the board of management of Bayer AG and president of Bayer’s …
-
Telemedicine Market Forecast Report and Company Analysis 2025-2033 Featuring Cisco, General Electric, Eli Lilly, Bayer, Honeywell Int'l, Merck, Teladoc Health, Ceva, and Twilio - ResearchAndMarkets.com
03 Apr 2025 16:54 GMT
… Company
Eli Lilly and Company
Bayer AG
Honeywell International Inc
Merck …
-
Steroidal Mineralocorticoid Receptor Antagonist Side Effects and Reasons for Discontinuation: A Patient Survey (RELICS-PS)
03 Apr 2025 11:16 GMT
…
This study was funded by Bayer AG.
Disclosure
ELR, JJS, VJW, and … , which was under contract by Bayer AG to perform this research. NRD …
-
North America Leads the Global Seeds Market: How Innovation and Demand Are Shaping the Future
03 Apr 2025 13:30 GMT
… market include:
BASF SE (Germany)
Bayer AG (Germany)
Syngenta (Switzerland)
KWS SAAT …
-
Vividion Therapeutics Doses First Patient in Phase I Study of RAS-PI3Kα Inhibitor for Treatment of Advanced Solid Tumors
03 Apr 2025 07:15 GMT
… and independently operated subsidiary of Bayer AG, utilizing innovative discovery technologies to … and independently operated subsidiary of Bayer AG, is a clinical stage biopharmaceutical …